· MagenTrust Research
Neuromorphic hardware brings brain-like computation to biomedical devices at the edge.
Our co-founders Michael Pendleton, Corrina Alcoser, and Jacqueline Suttin Loyland have published the first systematic analysis of why no neuromorphic medical device has reached regulatory clearance — and a phased roadmap to fix that by 2030.
Published April 9, 2026 • Zenodo DOI record 19478504
Edge AI in healthcare lives or dies by its power and latency budget. Neuromorphic silicon — built around spiking neural networks rather than dense matrix multiplication — has crossed thresholds that traditional accelerators cannot reach: seizure detection on wearables under 300 μW, arrhythmia classification compatible with coin-cell operation, and neuroprosthetic loops with sub-millisecond response. The hardware is real. The clinical pipeline is not.
The paper assigns Technology Readiness Level estimates across three primary clinical domains and evaluates hardware and algorithmic readiness across five dimensions: device variability, long-term stability, patient specificity, benchmark standardization, and algorithm–hardware co-design.
TRL 5–6 — closest to first-in-human feasibility.
TRL 4–5 — coin-cell viable, benchmark-limited.
TRL 3–4 — substrate biocompatibility unresolved.
The paper proposes a phased translational roadmap targeting first-in-human feasibility studies by 2028 and first regulatory clearance by 2030, with concrete actions assigned to chip manufacturers, standards bodies, regulators, and clinical research teams. It closes with ethical, equity, and data governance considerations for adaptive neuromorphic inference in vulnerable patient populations.
Our work on continuous behavioral verification at the edge — privacy-preserving inference, ephemeral state, and adaptive trust under power constraints — shares the same engineering substrate as neuromorphic biomedical AI. The same questions about deterministic verification, continuous learning, and accountable adaptation cut across both domains. This paper is part of the broader research program our team contributes to through UTSA and the NSCC.
The full 234 kB PDF is hosted on Zenodo with an open license.